Skip to main content
Oncotarget logoLink to Oncotarget
. 2018 Jun 19;9(47):28797. doi: 10.18632/oncotarget.25683

Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment

Hajer Ziouziou 1,2,3,4,7, Claudia Andrieu 1,2,3,4, Erik Laurini 5,6, Sara Karaki 1,2,3,4, Maurizio Fermeglia 5,6, Ridha Oueslati 7, David Taieb 1,2,3,4, Michel Camplo 6, Olivier Siri 8, Sabrina Pricl 5,6, Maria Katsogiannou 1,2,3,4, Palma Rocchi 1,2,3,4
PMCID: PMC6033366  PMID: 29983898

This article has been corrected: The proper listing of author names is given below:

Hajer Ziouziou1,2,3,4,7, Claudia Andrieu1,2,3,4, Erik Laurini5,6, Sara Karaki1,2,3,4, Maurizio Fermeglia5,6, Ridha Oueslati7, David Taieb1,2,3,4, Michel Camplo6, Olivier Siri8, Sabrina Pricl5,6, Maria Katsogiannou1,2,3,4 and Palma Rocchi1,2,3,4

Original article: Oncotarget. 2017; 8:77317-77329. https://doi.org/10.18632/oncotarget.20469


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES